Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 456

1.
2.

Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.

Kang MH, Yoo HJ, Kwon YH, Yoon HY, Lee SG, Kim SR, Yeom DW, Kang MJ, Choi YW.

Mol Pharm. 2015 Dec 7;12(12):4200-13. doi: 10.1021/acs.molpharmaceut.5b00399. Epub 2015 Nov 6.

PMID:
26544061
3.

Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation.

Kang MJ, Kim BG, Eum JY, Park SH, Choi SE, An JJ, Jang SH, Eum WS, Lee J, Lee MW, Kang K, Oh CH, Choi SY, Choi YW.

J Drug Target. 2011 Aug;19(7):497-505. doi: 10.3109/1061186X.2010.511226. Epub 2010 Aug 25.

PMID:
20738150
4.

RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.

Kang MH, Park MJ, Yoo HJ, hyuk KY, Lee SG, Kim SR, Yeom DW, Kang MJ, Choi YW.

Eur J Pharm Biopharm. 2014 Aug;87(3):489-99. doi: 10.1016/j.ejpb.2014.03.016. Epub 2014 Apr 2.

PMID:
24704199
5.

Pep-1 Peptide-modified liposomal carriers for intracellular delivery of gold nanoparticles.

Kang MJ, Lee S, Kim BK, Eum JY, Park SH, Kang MH, Oh CH, Choo J, Choi YW.

Chem Pharm Bull (Tokyo). 2011;59(1):109-12.

6.

Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.

Gao W, Xiang B, Meng TT, Liu F, Qi XR.

Biomaterials. 2013 May;34(16):4137-49. doi: 10.1016/j.biomaterials.2013.02.014. Epub 2013 Mar 1.

PMID:
23453200
7.

PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.

Jiang Y, Lv L, Shi H, Hua Y, Lv W, Wang X, Xin H, Xu Q.

Colloids Surf B Biointerfaces. 2016 Nov 1;147:242-249. doi: 10.1016/j.colsurfb.2016.08.002. Epub 2016 Aug 3.

PMID:
27518456
8.

Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.

Zhu Y, Cheng L, Cheng L, Huang F, Hu Q, Li L, Tian C, Wei L, Chen D.

Pharm Res. 2014 Dec;31(12):3289-303. doi: 10.1007/s11095-014-1418-z. Epub 2014 May 24.

PMID:
24858397
9.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
10.

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.

Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M, Gabizon A.

Mol Cancer Ther. 2006 Apr;5(4):818-24.

11.

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.

Ding N, Lu Y, Lee RJ, Yang C, Huang L, Liu J, Xiang G.

Int J Nanomedicine. 2011;6:2513-20. doi: 10.2147/IJN.S23934. Epub 2011 Oct 20.

12.

A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.

Huang Y, Yang T, Zhang W, Lu Y, Ye P, Yang G, Li B, Qi S, Liu Y, He X, Lee RJ, Xu C, Xiang G.

Int J Nanomedicine. 2014 Sep 29;9:4581-95. doi: 10.2147/IJN.S69115. eCollection 2014.

13.

Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.

Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J.

Int J Pharm. 2011 Mar 15;406(1-2):128-34. doi: 10.1016/j.ijpharm.2010.12.023. Epub 2010 Dec 23.

PMID:
21185364
14.

Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.

Chen J, Li S, Shen Q.

Eur J Pharm Sci. 2012 Sep 29;47(2):430-43. doi: 10.1016/j.ejps.2012.07.002. Epub 2012 Jul 10.

PMID:
22796217
15.

Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.

J Control Release. 2007 Dec 4;124(1-2):28-34. Epub 2007 Aug 30.

PMID:
17928088
16.

Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.

Leamon CP, Cooper SR, Hardee GE.

Bioconjug Chem. 2003 Jul-Aug;14(4):738-47.

PMID:
12862426
17.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
18.

Dual-targeted nanocarrier based on cell surface receptor and intracellular mRNA: an effective strategy for cancer cell imaging and therapy.

Pan W, Yang H, Zhang T, Li Y, Li N, Tang B.

Anal Chem. 2013 Jul 16;85(14):6930-5. doi: 10.1021/ac401405n. Epub 2013 Jul 2.

PMID:
23772649
19.

Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.

Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J.

Biomaterials. 2010 May;31(14):4129-38. doi: 10.1016/j.biomaterials.2010.01.089. Epub 2010 Feb 16.

PMID:
20163853
20.

Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.

Wang Y, Wang Y, Xiang J, Yao K.

Biomacromolecules. 2010 Dec 13;11(12):3531-8. doi: 10.1021/bm101013s. Epub 2010 Nov 18.

PMID:
21086982

Supplemental Content

Support Center